HomeInsightsMarket Capitalization

Market Capitalization of Glenmark Life Sciences Ltd

Market Capitalization of Glenmark Life Sciences Ltd

stocks purchased

₹ 1.0 Cr

Volume transacted

stocks purchased

8.5 K

stocks traded

Last Updated time: 04 Oct 13:16 PM

Image

Glenmark Life Sciences Ltd

NSE: GLS

MARKETCAP

13804.08 crore

Last updated: 03 Oct 24

Key Highlights

  • The Market Cap of Glenmark Life Sciences Ltd is ₹ 13804 crore as of 03 Oct 24.
  • The Market Cap of Glenmark Life Sciences Ltd changed from ₹ 5624 crore on March 2019 to ₹ 9499 crore on March 2024 . This represents a CAGR of 19.09% over 3 years. .
  • The Latest Trading Price of Glenmark Life Sciences Ltd is ₹ 1146 as of 04 Oct 13:09.

Historical Market Cap of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Company Fundamentals for Glenmark Life Sciences Ltd

No data available

Image

Glenmark Life Sciences Ltd

NSE: GLS

PRICE

1146.3

19.70 (1.75%)

stock direction

Last updated: 04 Oct 13:09

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Glenmark Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
03 Oct 20241126.6
01 Oct 20241124.05
30 Sep 20241058.3
27 Sep 20241031.85
26 Sep 20241018.6
25 Sep 20241056.35
24 Sep 20241107
23 Sep 20241138.75
20 Sep 20241150.75
19 Sep 20241189.15

SWOT Analysis Of Glenmark Life Sciences Ltd

Strength

2

S

Weakness

2

W

Opportunity

1

O

Threats

0

T

BlinkX Score for Glenmark Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Glenmark Life Sciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Glenmark Life Sciences Ltd

No data available

Historical P/E Ratio of Glenmark Life Sciences Ltd

No data available

* All values are in %

Historical Revenue of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical EBITDA of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical Dividend Payout of Glenmark Life Sciences Ltd

No data available

* All values are in %

About Glenmark Life Sciences Ltd

  • Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited', on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune.
  • Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' dated 10 August 2018.
  • A shareholders' resolution was passed on 13 August 2018 to convert the Company from a Private Limited Company to a Public Limited Company and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC.
  • The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited.
  • The Company acquired API Division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January, 2019.

Glenmark Life Sciences Ltd News Hub

News

Glenmark Life Sciences AGM scheduled

Glenmark Life Sciences announced that the Annual General Meeting (AGM) of the company will...

Read more

06 Sep 202416:35

News

Glenmark Life Sciences Ltd leads gainers in 'A' group

Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are amo...

Read more

05 Aug 202412:00

News

Glenmark Life drops after Q1 PAT slides 18% YoY to Rs 111 cr

Revenue from operations rose 1.75% YoY to Rs 588.62 crore in the first quarter of FY25. Pr...

Read more

26 Jul 202412:21

News

Glenmark Life Sciences to hold board meeting

Glenmark Life Sciences will hold a meeting of the Board of Directors of the Company on 25 ...

Read more

19 Jul 202410:41

News

Glenmark Life drops after Q4 PAT slides 33% YoY to Rs 98 cr; Generic API biz down 8% YoY

Revenue from operations fell 13.64% YoY to Rs 536.59 crore in Q4 FY24. Profit before tax d...

Read more

25 Apr 202415:41

News

Glenmark Life Sciences director resigns

Glenmark Life Sciences announced that Gita Nayyar (DIN: 07128438), has tendered her resign...

Read more

22 Apr 202411:10

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Glenmark Life Sciences Ltd

What is the market cap of Glenmark Life Sciences Ltd?

As of October 4, 2024, Glenmark Life Sciences Ltd has a market capitalization of ₹13804.08, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Glenmark Life Sciences Ltd's market capitalization?

Glenmark Life Sciences Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Glenmark Life Sciences Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Glenmark Life Sciences Ltd's market capitalization change?

Glenmark Life Sciences Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*